Solriamfetol Oral Tablet
2021-P-000509
Approved small_molecule terminated
Quick answer
Solriamfetol Oral Tablet for Excessive Sleepiness is a Approved program (small_molecule) at Axsome Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Excessive Sleepiness
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated